| Followers | 500 |
| Posts | 10140 |
| Boards Moderated | 0 |
| Alias Born | 04/28/2014 |
Saturday, December 02, 2017 1:21:06 PM
Recent CAPR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 11:15:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2026 09:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:01:07 PM
- Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2026 08:01:00 PM
- Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 03/12/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 03:01:36 PM
- Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA • GlobeNewswire Inc. • 03/10/2026 01:25:00 PM
- Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12 • GlobeNewswire Inc. • 03/09/2026 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/27/2026 12:10:54 AM
- Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference • GlobeNewswire Inc. • 02/24/2026 02:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/30/2026 10:01:12 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/26/2026 09:15:18 PM
- Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data • GlobeNewswire Inc. • 01/20/2026 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 09:45:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 07:55:05 PM
- Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 12/16/2025 09:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/05/2025 10:29:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:07:48 PM
- Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock • GlobeNewswire Inc. • 12/05/2025 11:15:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/05/2025 11:01:05 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/04/2025 09:30:18 PM
- Capricor Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 12/04/2025 09:01:00 PM
- Capricor jumps after DMD cell therapy succeeds in Phase 3 HOPE-3 study • IH Market News • 12/03/2025 02:46:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 02:29:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 12:21:12 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
